During the last session, Climb Bio Inc (NASDAQ:CLYM)’s traded shares were 0.37 million, with the beta value of the company hitting -0.27. At the end of the trading day, the stock’s price was $2.25, reflecting an intraday gain of 8.70% or $0.18. The 52-week high for the CLYM share is $11.55, that puts it down -413.33 from that peak though still a striking 23.11% gain since the share price plummeted to a 52-week low of $1.73. The company’s market capitalization is $151.25M, and the average intraday trading volume over the past 10 days was 0.62 million shares, and the average trade volume was 338.21K shares over the past three months.

Climb Bio Inc (NASDAQ:CLYM) trade information

Climb Bio Inc (CLYM) registered a 8.70% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 8.70% in intraday trading to $2.25, hitting a weekly high. The stock’s 5-day price performance is -0.88%, and it has moved by -28.57% in 30 days. Based on these gigs, the overall price performance for the year is -17.58%. The short interest in Climb Bio Inc (NASDAQ:CLYM) is 4.93 million shares and it means that shorts have 23.36 day(s) to cover.

Climb Bio Inc (CLYM) estimates and forecasts

Statistics show that Climb Bio Inc has underperformed its competitors in share price, compared to the industry in which it operates. Climb Bio Inc (CLYM) shares have gone down -66.06% during the last six months, with a year-to-date growth rate less than the industry average at -20.77% against 16.80.

An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -46.72%.

CLYM Dividends

Climb Bio Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.